Author(s)

Chenrui Luo, Yuezhi Wang

Corresponding Author

Yuezhi Wang

ABSTRACT

Cancer is a disease that confuse and torment people for hundreds of years, while human only know a little about it and the treatment seems not as effective as expectation. For many of years, scientists were seeking new treatments, the latest one was called targeted cancer cell therapy. Ideally, it targets on cancer cells and kill them without harming the normal cells, which is totally different from chemotherapy. Targeted cell therapy mainly based on medicines that can promote body immunity or weaken the cancer cell. There are several kinds of drugs that are commonly used in targeted cancer cell therapy, monoclonal antibody, agiogenesis inhibitors, proteasome inhibitors and signal transduction inhibitors.[1] For example, some monoclonal antibodies can help white blood cells to identify cancer cells quicker, while the others can help to destroy cancer cells from inside like a poison. [2] For every different kind of cancer, which means the different location of tumor, different kind of drug is used and their effectiveness is different. In this easy, two kinds of targeted cancer cell therapy used drugs will be discussed and evaluated.

KEYWORDS

Treatment, Cancer cell therapy, Monoclonal antibodies, Vitrakvi